| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +22.0% |
| Cost of Revenue | $135K | +1.7% |
| Gross Profit | $1.3M | +24.6% |
| R&D Expense | $15K | — |
| SG&A Expense | $1.6M | -4.0% |
| Operating Income | -$436K | +40.1% |
| Interest Expense | $13K | — |
| Pre-tax Income | -$408K | +49.0% |
| Net Income | -$436K |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91K | +97.7% |
| Accounts Receivable | $126K | -20.8% |
| Inventory | $208K | +14.6% |
| Current Assets | $487K | +5.1% |
| Total Assets | $935K | -5.2% |
| Current Liabilities | $3.1M | +14.9% |
| Long-term Debt | $150K | +0.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21K | +108.6% |
| Capital Expenditures | $38K | -38.2% |
| Investing Cash Flow | -$38K | +26.9% |
| Financing Cash Flow | $62K | -78.4% |
| Free Cash Flow | -$17K | +94.5% |
| +47.0% |
| Total Liabilities |
| $3.3M |
| +12.2% |
| Stockholders' Equity | -$2.4M | -20.9% |